Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Ashley Wysong et al. Dermatol Ther (Heidelb) 2024

https://phgkb.cdc.gov/PHGKB/phgHome.action?action=update